ArticleFrontiers in digital health2025
Comprehensive evaluation framework for synthetic tabular data in health: fidelity, utility and privacy analysis of generative models with and without privacy guarantees.
Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- CLEO closed loop framework for synthesizing medical privacy preserving tabular data.NPJ digital medicine · 2026Article
- Artificial intelligence-generated synthetic data for cancer research and clinical trials.Nature reviews. Cancer · 2026Review
- The Potential of Digital Twins for Pediatric Rare Diseases.CPT: pharmacometrics & systems pharmacology · 2026Review
- Who's afraid of synthetic data? Hybrid approaches to deliver medical digital twins.Informatics in medicine unlocked · 2026Article
- Implementing generative artificial intelligence in precision oncology: safety, governance, and significance.Journal of hematology & oncology · 2026Review
- A call for principle-based acceptance of synthetic patients: establishing the AI-driven foundation for regulatory submissions.Frontiers in digital health · 2026Review
- A Comprehensive Survey on Intrusion Detection Systems for Healthcare 5.0: Concepts, Challenges, and Practical Applications.Sensors (Basel, Switzerland) · 2025Review
- Synthetic Tabular Data Generation Under Horizontal Federated Learning Environments in Acute Myeloid Leukemia: Case-Based Simulation Study.JMIR medical informatics · 2025Article
- Privacy-, linguistic-, and information-preserving synthesis of clinical documentation through generative agents.Frontiers in artificial intelligence · 2025Article
- On the use of synthetic data for healthcare AI in Africa: Technical performance, governance challenges, and policy readiness.Digital healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The generation of synthetic tabular data has emerged as a key privacy-enhancing technology to address challenges in data sharing, particularly in healthcare, where sensitive attributes can compromise patient privacy. Despite significant progress, balancing fidelity, utility, and privacy in complex medical datasets remains a substantial challenge. This paper introduces a comprehensive and holistic evaluation framework for synthetic tabular data, consolidating metrics and privacy risk measures across three key categories (fidelity, utility and privacy) and incorporating a fidelity-utility tradeoff metric. The framework was applied to three open-source medical datasets to evaluate synthetic tabular data generated by five generative models, both with and without differential privacy. Results showed that simpler models generally achieved better fidelity and utility, while more complex models provided lower privacy risks. The addition of differential privacy enhanced privacy preservation but often reduced fidelity and utility, highlighting the complexity of balancing fidelity, utility and privacy in synthetic data generation for medical datasets. Despite its contributions, this study acknowledges limitations, such as the lack of evaluation metrics neither privacy risk measures for required model training time and resource usage, reliance on default model parameters, and the assessment of models that incorporates differential privacy with only a single privacy budget. Future work should explore parameter optimization, alternative privacy mechanisms, broader applications of the framework to diverse datasets and domains, and collaborations with clinicians for clinical utility evaluation. This study provides a foundation for improving synthetic tabular data evaluation and advancing privacy-preserving data sharing in healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.